November 9, 2016
Oxford Pharma's OXPzero Ibuprofen going back into the clinic
Oxford Pharma’s OXPzero Ibuprofen going back into the clinic
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
November 9, 2016
Valneva reports financial results for first nine months of 2016
Valneva has reported financial results for first nine months of 2016.
November 9, 2016
Nicox: update on Latanoprostene bunod and AC-170
Nicox S.A., the international ophthalmic R&D company, has provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170.
November 8, 2016
GENFIT's revenue halves in Q3 2016
GENFIT has today announced its cash and cash equivalents as at September 30, 2016
November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
November 7, 2016
Testing investigational Zika vaccine candidate in humans
The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine
November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
November 7, 2016
Orphan drugs make 35% Horizon's sale in Q3 2016
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
November 7, 2016
Neovacs enroles first U.S. patient in its Phase IIb study of IFNalpha Kinoid in lupus.
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
November 7, 2016
Amryt gets FDA's designation for orphan drug to treat acromegaly
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…